Twist Bioscience Corporation
TWST
$29.70
-$0.16-0.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -77.67M | -85.19M | -191.15M | -197.31M | -208.73M |
| Total Depreciation and Amortization | 21.95M | 22.91M | 25.14M | 27.04M | 28.83M |
| Total Amortization of Deferred Charges | 2.90M | 2.60M | 2.60M | 2.60M | 2.60M |
| Total Other Non-Cash Items | 17.80M | 15.31M | 105.28M | 98.43M | 97.79M |
| Change in Net Operating Assets | -12.61M | -6.76M | 2.02M | 6.69M | 15.41M |
| Cash from Operations | -47.63M | -51.13M | -56.11M | -62.55M | -64.09M |
| Capital Expenditure | -28.00M | -17.58M | -9.38M | -5.84M | -5.08M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 2.50M | 2.50M | -- | -- | -- |
| Other Investing Activities | 742.00K | 1.44M | 4.42M | -2.93M | 2.01M |
| Cash from Investing | -24.76M | -13.64M | -4.96M | -8.77M | -3.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.56M | 11.62M | 12.70M | 12.86M | 10.87M |
| Repurchase of Common Stock | -16.00K | -22.00K | -26.00K | -1.56M | -3.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.00M | 15.00M | 15.00M | 15.00M | -- |
| Cash from Financing | 28.54M | 26.59M | 27.68M | 26.31M | 6.89M |
| Foreign Exchange rate Adjustments | 143.00K | 53.00K | 126.00K | -43.00K | 126.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.71M | -38.13M | -33.27M | -45.06M | -60.15M |